UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies (UKGPCS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01737242|
Recruitment Status : Recruiting
First Posted : November 29, 2012
Last Update Posted : April 4, 2022
The UKGPCS was set up to find genetic alterations which occur in patients who have prostate cancer.
A man's risk of developing prostate cancer increases if he has a first-degree relative (father or brother) who was diagnosed with prostate cancer at a young age. This is why we are looking for men who are affected at a young age or who have a family history of prostate cancer, since it is more probable that these prostate cancers are due to an inherited genetic cause rather than an environmental cause.
We also ask all men who come to the Royal Marsden Hospital to be treated for prostate cancer if they would like to take part in the study so that we can also look to see if we find genetic alterations in older men, and those who do not have a family history of prostate cancer.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||26000 participants|
|Official Title:||UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies|
|Study Start Date :||January 1993|
|Estimated Primary Completion Date :||December 2022|
|Estimated Study Completion Date :||December 2022|
- To find genes which predispose to PrCa [ Time Frame: 2017 ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01737242
|Contact: Rosalind A Eeles, FRCP FRCRemail@example.com|
|Institute of Cancer Research and Royal Marsden Hospital||Recruiting|
|Sutton, Surrey, United Kingdom, SM2 5PT|
|Contact: Rosalind A Eeles, FRCP FRFR 02086613642 firstname.lastname@example.org|
|Principal Investigator: Rosalind A Eeles, FRCP FRCR|
|Principal Investigator:||Rosalind A Eeles, FRCP FRCR||Institute of Cancer Research and Royal Marsden Hospital|